ArticleAmerican journal of cancer research2026
Restoring osimertinib sensitivity in EGFR-mutant NSCLC: the role of anlotinib in modulating Wnt/β-catenin/YAP pathways.
Xuquan Jing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.